Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 crore

Will be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MZxPlOS
via IFTTT

Read More

Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenue

Gland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer, manufacturing and supply of sterile injectable products. The agreement covers 55 SKUs across three sites, with annualised revenue potential of $90-100 million upon commercialisation. Revenue generation is expected to begin in 2029.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aBfGJPW
via IFTTT

Read More

IIT Guwahati develops 'E-Eye' for rapid detection of Cancer-causing heavy metals and other toxicants

IIT Guwahati researchers have developed an innovative optical sensing device for detecting water toxicants. This portable E-Eye device offers instant and accurate on-site analysis of various contaminants. It works by converting chemical reactions into digital data for easy interpretation. The technology aligns with the Jal Jeevan Mission, aiming to ensure safe drinking water for all. This innovation holds significant potential for government, industry, and public health applications.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LCGKXBI
via IFTTT

Read More

Govt plans new drugs law to overhaul pharma, medical device regulation

The government is set to replace the 1940 Drugs and Cosmetics Act with a new law covering drugs, medical devices and cosmetics. The draft bill strengthens the powers of the DCGI, introduces stricter bail provisions for serious drug offences, enables faster approvals and recalls, and creates dedicated regulatory and advisory bodies for medical devices.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oAaKHfU
via IFTTT

Read More

Emcure Pharma net profit up 36% at Rs 292 crore

Emcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivity gains. Net profit saw a significant 36.2% rise during the period. The company began its five-year plan on a strong footing for FY27. Emcure also completed the acquisition of a minority stake in Gennova Biopharmaceuticals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6Lxt2Mk
via IFTTT

Read More

KKR deepens India healthcare bet with $1.39 billion Medicover acquisition

Global investment firm KKR has acquired Medicover India's hospital network for $1.39 billion. This acquisition marks KKR's third hospital purchase in recent years. Medicover India operates 24 multi-specialty hospitals across South and West India. The European healthcare chain will now focus its operations solely within the continent. This transaction allows Medicover to strengthen its financial position and pursue European growth.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0zUcEjF
via IFTTT

Read More

Centre to bar drugmakers from selling mislabelled, fraudulently approved products under new provisions

New rules will bar drugmakers from selling products if false information was provided. The Union Ministry of Health & Family Welfare has amended the Drugs Rules, 1945. This adds accountability for drug manufacturers and distributors operating in the country. The Licensing Authority can now debar entities from filing future applications. This amendment aims to deter misconduct and ensure reliable drug approval evidence.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/B15tvuK
via IFTTT

Read More